These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Coagulation factor Xa: the prothrombinase complex as an emerging therapeutic target for small molecule inhibitors. Scarborough RM J Enzyme Inhib; 1998; 14(1):15-25. PubMed ID: 10520757 [No Abstract] [Full Text] [Related]
24. Molecular modeling studies of novel retro-binding tripeptide active-site inhibitors of thrombin. Lau WF; Tabernero L; Sack JS; Iwanowicz EJ Bioorg Med Chem; 1995 Aug; 3(8):1039-48. PubMed ID: 7582978 [TBL] [Abstract][Full Text] [Related]
25. Design, synthesis and SAR of a series of 1,3,5-trisubstituted benzenes as thrombin inhibitors. Isaacs RC; Newton CL; Cutrona KJ; Mercer SP; Payne LS; Stauffer KJ; Williams PD; Cook JJ; Krueger JA; Lewis SD; Lucas BJ; Lyle EA; Lynch JJ; McMasters DR; Naylor-Olsen AM; Michener MT; Wallace AA Bioorg Med Chem Lett; 2011 Mar; 21(5):1536-40. PubMed ID: 21295467 [TBL] [Abstract][Full Text] [Related]
26. Recent advances in serine protease inhibitors as anticoagulant agents. Prezelj A; Anderluh PS; Peternel L; Urleb U Curr Pharm Des; 2007; 13(3):287-312. PubMed ID: 17313362 [TBL] [Abstract][Full Text] [Related]
27. Potent and efficacious thienylamidine-incorporated thrombin inhibitors. Lee K; Hwang SY; Yun M; Kim DS Bioorg Med Chem Lett; 1998 Jul; 8(13):1683-6. PubMed ID: 9873414 [TBL] [Abstract][Full Text] [Related]
28. New tripeptidic thrombin inhibitors. Influence of P2 and P3 residues on activity and selectivity. De Nanteuil G; Gloanec P; Lila C; Portevin B; Boudon A; Rupin A; Verbeuren TJ Bioorg Med Chem; 1995 Aug; 3(8):1019-24. PubMed ID: 7582976 [TBL] [Abstract][Full Text] [Related]
29. Structure-activity and crystallographic analysis of a new class of non-amide-based thrombin inhibitor. Lu T; Soll RM; Illig CR; Bone R; Murphy L; Spurlino J; Salemme FR; Tomczuk BE Bioorg Med Chem Lett; 2000 Jan; 10(1):79-82. PubMed ID: 10636249 [TBL] [Abstract][Full Text] [Related]
30. How a β-D-glucoside side chain enhances binding affinity to thrombin of inhibitors bearing 2-chlorothiophene as P1 moiety: crystallography, fragment deconstruction study, and evaluation of antithrombotic properties. Belviso BD; Caliandro R; de Candia M; Zaetta G; Lopopolo G; Incampo F; Colucci M; Altomare CD J Med Chem; 2014 Oct; 57(20):8563-75. PubMed ID: 25268757 [TBL] [Abstract][Full Text] [Related]
31. Discovery of non-competitive thrombin inhibitor derived from competitive tryptase inhibitor skeleton: Shift in molecular recognition resulted from skeletal conversion of carboxylate into phosphonate. Aoyama H; Ijuin R; Kato JY; Urushiyama S; Tetsuhashi M; Hashimoto Y; Yokomatsu T Bioorg Med Chem Lett; 2015 Sep; 25(17):3676-80. PubMed ID: 26122211 [TBL] [Abstract][Full Text] [Related]
36. Identification and characterization of novel salivary thrombin inhibitors from the ixodidae tick, Haemaphysalis longicornis. Iwanaga S; Okada M; Isawa H; Morita A; Yuda M; Chinzei Y Eur J Biochem; 2003 May; 270(9):1926-34. PubMed ID: 12709051 [TBL] [Abstract][Full Text] [Related]
37. Active site-directed thrombin inhibitors: alpha-hydroxyacyl-prolyl-arginals. New orally active stable analogs of D-Phe-Pro-Arg-H. Bajusz S; Barabás E; Fauszt I; Fehér A; Horváth G; Juhász A; Szabó AG; Széll E Bioorg Med Chem; 1995 Aug; 3(8):1079-89. PubMed ID: 7582981 [TBL] [Abstract][Full Text] [Related]
38. Structure-based design of thrombin inhibitors. Pfau R Curr Opin Drug Discov Devel; 2003 Jul; 6(4):437-50. PubMed ID: 12951807 [TBL] [Abstract][Full Text] [Related]
39. Novel anticoagulants based on direct inhibition of thrombin and factor Xa. Gardell SJ; Sanderson PE Coron Artery Dis; 1998; 9(2-3):75-81. PubMed ID: 9647407 [No Abstract] [Full Text] [Related]
40. Site-specific dissection of substrate recognition by thrombin. Vindigni A; Dang QD; Di Cera E Nat Biotechnol; 1997 Sep; 15(9):891-5. PubMed ID: 9306406 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]